To kliniske fase III forsøg blev gennemført med i alt 851 postmenopausale kvinder med avanceret brystcancer, som havde sygdomstilbagefald under, eller efter, adjuvant endokrin behandling, eller progression efter endokrin behandling for avanceret sygdom.
Clinical safety and efficacy in advanced breast cancer Two phase III clinical trials were completed in a total of 851 postmenopausal women with advanced breast cancer who had disease recurrence on or after adjuvant endocrine therapy or progression following endocrine therapy for advanced disease.